Press Releases

May 10, 2022
SAN DIEGO --(BUSINESS WIRE)--May 10, 2022-- DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain , Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences: BofA Securities 2022 Healthcare Conference on
Apr 28, 2022
SAN DIEGO --(BUSINESS WIRE)--Apr. 28, 2022-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2022 . First Quarter 2022 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $628.8 million on a reported basis
Apr 07, 2022
Report advances Dexcom’s environmental, social, and governance (ESG) transparency by providing new disclosures including company’s first Sustainability Accounting Standards Board (SASB) index SAN DIEGO --(BUSINESS WIRE)--Apr. 7, 2022-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time
Mar 25, 2022
SAN DIEGO --(BUSINESS WIRE)--Mar. 25, 2022-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today that its Board of Directors has approved a four-for-one forward split (the “Stock Split”) of Dexcom’s common stock.
Displaying 1 - 10 of 18